PLoS ONE (Jan 2021)

Lower p66Shc promoter methylation in subjects with chronic renal failure.

  • Radhia Hamdi,
  • Amana Saadallah-Kallel,
  • Slima Ferchichi-Trimeche,
  • Raja Mokdad-Gargouri,
  • Abdelhedi Miled,
  • Bachir Benarba

DOI
https://doi.org/10.1371/journal.pone.0257176
Journal volume & issue
Vol. 16, no. 9
p. e0257176

Abstract

Read online

ObjectiveTo determine the correlation between DNA methylation of p66Shc promoter and some markers of inflammatory and oxidative stress in chronic renal failure (CRF) patients compared with healthy subjects.MethodsAn observational cross-sectional study was conducted in the nephrology department at Sidi Bouzid Regional Hospital (Tunisia). In total, 39 patients with CRF and 37 healthy subjects were included. Several biochemical parameters were measured. Furthermore, markers of the oxidative and inflammatory status (MDA, TAS, SOD, and CRP) were evaluated. The p66Shc methylation status was determined using the methylation-specific PCR.ResultsOur results showed that levels of blood glucose, urea, creatinine, uric acid, ChT, TG, albuminuria, CRP and MDA were significantly elevated in CRF patients compared to controls. Furthermore, p66Shc promoter region was highly demethylated in CRF patients compared to healthy controls (84% vs 4%). Our data showed a positive correlation between p66Shc hypomethylation and levels of MDA (r = 0.93; pConclusionThis study indicates that the DNA hypomethylation of p66shc promoter was correlated with oxidative and inflammatory stress and the disease stages in CRF patients.